Iron Metabolism in Obesity (NCT07157332)
Dysregulation of Iron Metabolism in Obese Individuals and Its Implications for Metabolic Health
🩺 Plain-English Summary (8th-Grade Level)
This study consists of two phases and aims to understand how obesity and systemic iron deficiency affect iron accumulation in important organs such as the liver and heart, as well as oxidative stress in fat tissue cells. In Phase 1, researchers will compare individuals with obesity who have iron deficiency to those without, to see if there are differences in the amount of iron stored in the liver and heart, measured by magnetic resonance imaging (MRI), and in oxidative stress and labile iron in visceral and subcutaneous fat tissue, assessed through biopsies. Phase 2 is a six-month prospective cohort study following the same individuals after they undergo bariatric surgery, a weight-loss surgery. The goal is to evaluate whether weight and fat loss normalize iron accumulation in the liver and heart, reduce oxidative stress, improve systemic iron metabolism, enhance blood sugar control, support liver function, modulate chronic inflammation, and restore gut microbiota diversity. Researchers will compare these health changes between individuals with and without iron deficiency. The study includes adults aged 18 to 50 with obesity living in the metropolitan area of Monterrey, Mexico, who are scheduled for laparoscopic sleeve gastrectomy surgery and agree to participate. The findings could improve understanding of how iron metabolism interacts with obesity-related complications and may lead to better treatments and management strategies for people with obesity and iron deficiency.
Who can join: Review the eligibility criteria below.
Location: Fundación Santos y de la Garza Evia, IBP — San Pedro Garza García, Nuevo León
Age range: 18 Years to 50 Years
🧪 Interventions in This Study
- Bariatric Sleeve Surgery (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Fundación Santos y de la Garza Evia, IBP — San Pedro Garza García, Nuevo León
📞 Contact the Study Coordinator
Phone: (210) 882-2059
Email: ana.cepeda@tecsalud.mx
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity (Disorder)
- Effects of Gallotannins on the Gut Microbiome and How it Affects Inflammatory Markers Among Obese Individuals. — Prairie View, Texas
- Continuous Glucose Monitoring in Metabolic Surgery — Baton Rouge, Louisiana
- Healthy Living Anson Study — Chapel Hill, North Carolina
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity — Hamilton, Ontario
- Repeated Far Infrared Sauna Bathing in Adults With Obesity — Eugene, Oregon
Explore by condition: All Obesity (Disorder) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.